Life Science Talks – Healthcare in transformation

We have the pleasure of inviting you to our next Life Science Talks entitled “Healthcare in transformation – getting stakeholder interactions right” taking place on Wednesday, 12th June 2019 at La Maison de la Recherche in the heart of Paris.

The fact that technology is transforming the way Life Science companies engage their customers is a favourite industry maxim. At the same time the customer landscape is evolving beyond the traditional focus on health care professionals. There are many opportunities for Life Science companies to interact with stakeholders: patients can be engaged through AI –powered chat boxes, online platforms can be mined for data and digital services can improve patient outcomes. Meanwhile prescribers are targeted through multi or even omni channel marketing models and providers/payers are keen to play an increasing role in shaping how therapies impact the holistic care pathway.In this evolving landscape the human factor is as crucial as the technological enabler and determines whether a service is adding value or draining resources.Understanding how the technology engages a stakeholder in their universe helps life science players define service benefits. Join us in exploring how the way we interact across healthcare stakeholders is evolving, the role technology plays and what new relationships are emerging.

THE SCHEDULE

15:30 – Welcome coffee

16:00 – Introduction by Sébastien Stoitzner & Chris Isler

16:15 – Keynote speaker

17:00 – Break

17:30 – Roundtable and Q&A

19:30 – Cocktail

THE SPEAKERS

KEYNOTE SPEAKER

Professor Gérard Reach, MD Diabetologist, AP-HP – Author of “The Mental Mechanisms of Patient Adherence to Long-Term Therapies, Mind and Care", and "Clinical Inertia, a Critique of Medial Reason", Springer, 2015: “Shared Decision Making, a humanistic answer to a medical crisis".

Professor Gérard Reach, MD

Metabolic Diseases AP HP – Author of a book on Patient Adherence

About

Professor Gérard Reach, MD

Diabetologist, AP-HP – Author of “The Mental Mechanisms of Patient Adherence to Long-Term Therapies, Mind and Care”, and “Clinical Inertia, a Critique of Medial Reason”, Springer, 2015:

“Shared Decision Making, a humanistic answer to a medical crisis”.

THE SPEAKERS

We will discuss whether our current models of care are still fit for purpose and the social implications of changing the care models. In addition, we will focus on how new technologies, such as sensors, AI and robotics change the way ‘care’ is delivered.

SPEAKERS PANEL

Following the Intercell-Vivalis merger, Franck Grimaud was appointed President and Chief Business Officer (CBO) of Valneva. He co-founded Vivalis in 1999 serving as its CEO and “President du Directoire”. He has a long management track record, with more than 20 years of experience in various industries, including 14 years in the biopharmaceutical sector. Before building up Vivalis he was responsible for the creation of the Chinese, Malaysian and Thailand subsidiaries of Groupe Grimaud, a worldwide leader in animal genetic selection and currently Valneva’s largest shareholder. Franck Grimaud holds an MBA from the University of Ottawa (Canada).

Franck Grimaud

Deputy CEO, VALNEVA SE

About

Following the Intercell-Vivalis merger, Franck Grimaud was appointed President and Chief Business Officer (CBO) of Valneva. He co-founded Vivalis in 1999 serving as its CEO and “President du Directoire”. He has a long management track record, with more than 20 years of experience in various industries, including 14 years in the biopharmaceutical sector. Before building up Vivalis he was responsible for the creation of the Chinese, Malaysian and Thailand subsidiaries of Groupe Grimaud, a worldwide leader in animal genetic selection and currently Valneva’s largest shareholder. Franck Grimaud holds an MBA from the University of Ottawa (Canada).

Ralph Schimmer, MD

Chief Medical Officer and Senior Vice President at Roche. Professor of Medicine at University of Zurich Medical School.

About

Experienced healthcare and pharmaceutical industry professional. Preclinical and clinical research, clinical development, and extensive medical practice experience in the areas of metabolism, inflammation/inflammatory diseases, infectious diseases/sepsis, pulmonary diseases, cardiovascular diseases, gastrointestinal diseases, emergency medicine, critical care.
Higher education professional with lectureship as Professor of Human Medicine at University of Zurich Medical School.
Extensive Pharmaceutical and Diagnostics industry experience in Medical Affairs as well as Clinical Development (including global product registrations), Clinical Science, Drug Safety Risk Management, Pharmaceutical Labeling, Marketing and Sales, complex project management, site management and site leadership.
Global work experience including NA, LATAM and APAC regions.
Currently in international leadership position as Head Global Medical & Scientific Affairs and Chief Medical Officer for Roche Diagnostics CPS, leading a department with 200+ employees at various international sites (Germany, Switzerland, USA, China, Colombia) and 3 functional areas (Clinical Science, Clinical Operations, Medical Affairs) covering Clinical Research and Development and Medical Affairs leadership.

Francesca Wuttke

Chief Digital Officer (CDO) at Almirall

About

Francesca Domenech Wuttke, Ph.D. is the Chief Digital Officer of Almirall where she is developing and executing an end-to-end companywide digital transformation. She is responsible for finding use cases across R&D, commercial, manufacturing, finance, legal and HR to apply digital solutions and services to bring efficiencies in terms of time and cost and to open up new business channels for Almirall. Dr. Wuttke brings with her broad drug development and healthcare expertise in both the US and Europe, with over 20 years of clinical, commercial, strategic and transactional experience. She has worked with diverse organizations including start-ups, consulting, large and specialty pharma as well as academia. Most recently, she led European investments as Managing Director for the MSD Global Health Innovation Fund, LLC. Previously Dr. Wuttke led Almirall´s Corporate Development Strategy team to transact on both med device and pharma M&A opportunities with a new and targeted focus for the company. Before that Dr. Wuttke worked at Novartis where she was responsible for two Cell and Gene therapy opportunities that were successfully brought into the organization as well as managing the strategy and commercialization for the existing portfolio of cell therapy assets. Dr. Wuttke holds a Ph.D. in Pharmacology from Weill Cornell Graduate School of Medical Sciences and a BA from Cornell University College of Arts and Sciences

Emilie Bugeat

General Manager Upjohn Division (Pfizer) – France

About

Emilie is President and General Manager of Upjohn Division in France for Pfizer. She leads a 90M$ business focused on 16 Pfizer iconic brands and their Pfizer generics. Emilie is a leader of transformational projects with long experience of building high performing teams and new operating models. Lately, she created the EU Customer Marketing strategic roadmap for Pfizer Essential Health (4B$), focusing on customers & patients journeys and digital transformation. She also ran important initiatives at regional and local level in France focusing on developing  organizational agility & capabilities for evolving commercial needs. Emilie has been for the last 13 years at Pfizer, where she has held various roles at local and regional level in Business and Commercial Operations organizations

Chris Isler – Moderator

Integrated Healthcare expert and country head Switzerland, PA Consulting Group

About

Chris Isler is life science expert and head of Switzerland at PA Consulting with a long-term life science executive experience and an extensive background in Integrated Healthcare Solutions and Commercial Development across Europe and the US. Having worked for one of world´s leading Pharmaceutical companies he pioneered the development and commercialisation of patient centric Healthcare Solutions by combining life science, behaviour change and technology approaches into holistic outcomes-based offerings.

Sébastien Stoitzner

CEO, GenSearch

About

Sébastien founded GenSearch in 2010, after seven years as Europe Life Sciences Team Leader within a leading global executive search consultancy.

During these years, he actually recruited and assessed hundreds of executives for the Global Life Sciences/Healthcare market. He also participated in strategic Recruitment Process Outsourcing projects for the global or regional HR Departments of Life Science market leaders. He was also the consultancy’s key user of ACs (assessment centers) and developed an array of assessment tools, dedicated to specific healthcare market roles.

Sébastien graduated from the Ecole Nationale Supérieure de Physique de Strasbourg (1996 – Physics Engineering School), with a specialization in biomedical engineering. After a few experiences within prestigious biology research centers (Institut Pasteur, Inserm, IRCAD), he began his career as a biomedical engineer in a French military hospital.

Following this experience, he joined companies dedicated to the maintenance and control of medical equipment: successively, CGEM (initially, the subsidiary of the first French Private Hospital Group, Générale de Santé, later acquired by GE Healthcare), and AMTECH Médical, as Sales and Tech manager.

After an experience as BU Manager at Alten, an engineering and IT consulting group, as recruitment became a major part of his role, he decided to focus on HR topics and joined a leading global executive search firm.

About GenSearch

GenSearch is an International Executive Search and HR services consultancy dedicated to the Life Sciences. Our focus covers the Pharmaceutical, Medical Devices and Biotechnology industries. We work with clients who are in different stages of their business lifecycle from small Biotechnology companies just starting out to large multinational healthcare companies. We work closely with all of our clients to add value and performance to their business. Our goal is to also help executives build a successful career in line with their aspirations and the market reality using our extensive sector knowledge.

www.gensearch-consulting.com

About PA Consulting Group

An innovation and transformation consultancy, we believe in the power of ingenuity to build a positive human future in a technology-driven world.As strategies, technologies and innovation collide, we turn complexity into opportunity.Our diverse teams of experts combine innovative thinking and breakthrough technologies to progress further, faster. Our clients adapt and transform, and together we achieve enduring results.We are over 2,800 specialists in consumer, defence and security, energy and utilities, financial services, government, healthcare, life sciences, manufacturing, and transport, travel and logistics. And we operate globally from offices across the Americas, Europe, the Nordics and the Gulf.

PA. Bringing Ingenuity to Life

www.paconsulting.com

EVENT
DETAILS

PARIS, FRANCE

12thJUNE 2019

from 3.30 pm

MAISON DE LA RECHERCHE

54 rue de Varenne
75007 Paris